Contract award notice

Results of the procurement procedure

Section I: Contracting entity

I.1) Name and addresses

I.4) Type of the contracting authority

Regional or local authority

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.2) Description

Section IV: Procedure

IV.1) Description

Section V: Award of contract

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

01/10/2024

V.2.2) Information about tenders

Number of tenders received: 1

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 316 548.00  GBP

V.2.5) Information about subcontracting

Section VI: Complementary information

VI.3) Additional information

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by 12/11/2024. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.<br/><br/>Written representations can be sent to: Lisa.Johnston@mkuh.nhs.uk<br/><br/>Award decision makers: <br/>Jonathan Dunk – Chief Finance Officer<br/>Fay Gordon – Chief Operating Officer<br/>Claire McGillycuddy - ADO Surgery and Planned Care General Surgery<br/>Arosha Hettiarachchige - Operational Manager General Surgery<br/><br/>Conflicts of interest identified: none. <br/><br/>Key Criteria 1: Quality and Innovation<br/><br/>The Vascular service currently doesn't have a treatment option for varicose vein patients. The vein centre offers this treatment to our patients who are currently sitting on our PTL. Prior to having this option our patients would remain on the PTL and became long waiters. There is a plan to move away from the Vein Centre once we offer radiofrequency ablation in the Treatment room. <br/><br/>This outsourcing solution should align to the following:<br/>• Have the ability to align capacity with the defined volumes to acheive the clearance rate required<br/>• Have defined Governance processes that dovetail to MKUH's to ensure quality is monitored and delivered to achieve optimal patient outcomes<br/><br/>The current insourcing provider is successfully delivering against the ciriteria.<br/><br/>• Given capacity constraints around varicose vein treatment volumes within the contract have been increased.<br/>• The insourcing provider will configure service delivery within confines of the contract.<br/><br/>Key criteria 2: Value <br/>The value of the contract is £316,548 over a period of 6 months, and should deliver the following non-finanical benefits:<br/>• Reduction in backlogs<br/>• Increase access to timely care and treatment<br/>• Improved patient experience<br/><br/>The current insourcing provider is successfully delivering against the criteria.<br/><br/>• Given capacity constraints around varicose vein treatment volumes within the contract have been increased.<br/>• The insourcing provider will configure service delivery within confines of the contract.<br/><br/><br/>Key criteria 3: Integration, collaboration and service sustainability<br/><br/>Since the Vascular service is unable to currently offer varicose vein patients with treatment, not having the Vein Centre would lead to an increase in our long waiters. This will result in compromising patient safety, care and experience. Keeping the outsourcing service would ensure that we continue to tackle backlog of longest waiting patients for varicose vein treatment. <br/><br/>This outsourcing solution should align to the following:<br/>• Have the ability to align capacity with the defined volumes to achieve the clearance rate required<br/>• Have defined Governance processes that dovetail to MKUH's to ensure quality is monitored and delivered to achieve optimal patient outcomes.<br/><br/>The current insourcing provider is successfully delivering against the criteria.<br/><br/>• Given capacity constraints around varicose vein treatment volumes within the contract have been increased.<br/>• The insourcing provider will configure service delivery within confines of the contract.<br/><br/>Key criteria 4: Improving access, reducing health inequalities and facilitating choice<br/><br/>Since the Vascular service is unable to currently offer varicose vein patients with treatment, not having the Vein Centre would lead to an increase in our long waiters. This will result in compromising patient safety, care and experience. Keeping the outsourcing service would ensure that we continue to tackle backlog of longest waiting patients for varicose vein treatment. <br/><br/>This outsourcing solution should align to the following:<br/>• Have the ability to align capacity with the defined volumes to achieve the clearance rate required.<br/>• Have defined Governance processes that dovetail to MKUH's to ensure quality is monitored and delivered to achieve optimal patient outcomes<br/><br/>The current insourcing provider is successfully delivering against the criteria.<br/><br/>• Given capacity constraints areound varicose vein treament volumes within the contract have been increased.<br/>• The insourcing provider will configure service delivery within confines of the contract.<br/><br/>Key Criteria 5: Social Value<br/>Given that the treatment is currently not offered at MKUH the outsourcing provider will deliver the following benefits in relation to social value:<br/><br/>• Reduced human suffering<br/>• Increase access to varicose vein care/ treatment.<br/><br/>The current insourcing provider is successfully delivering against the criteria.<br/><br/>• Given capacity constraints around varicose vein treatment volumes within the contract have been increased.<br/>• The insourcing provider will configure service delivery within confines of the contract.<br/><br/>Basic selection criteria: <br/>The provider was selected based on the weighting of the following criteria:<br/>• Experience in delivering pathways aligned to the the treatment of varicose veins<br/>• Have the ability to align capacity with the defined volumes to acheive the clearance rate required <br/>• Have defined Governance processes that dovetail to MKUH's to ensure quality is monitored and delivered to achieve optimal patient outcomes

VI.4) Procedures for review

VI.5) Date of dispatch of this notice

31/10/2024